elixir bpc 157 BPC-157: Experimental Peptide Creates Risk for Athletes BPC-157 — ≥99% Purity, COA
Description
It has not been approved for any clinical indication in humans
As of 2026, retatrutide has not received marketing authorisation from the MHRA or EMA and is only accessible within authorised clinical trials
This is the reason why we undergo independent lab testing for each product to check the quality and purity
This is me experimenting and adding one little piece here, and one little piece there
